Repligen (RGEN) Non-Current Deferred Tax Liability (2011 - 2026)
Repligen's (RGEN) quarterly Non-Current Deferred Tax Liability came in at $15.0 million in Q1 2026, down 37.78% year-on-year from $24.1 million in Q1 2025, and down 33.24% on a QoQ basis from $22.5 million in Q4 2025.
Repligen (RGEN) Non-Current Deferred Tax Liability (2011 - 2026) Analysis & Trends
Repligen (RGEN) has 15 years of Non-Current Deferred Tax Liability data on file, last reported at $15.0 million in Q1 2026.
- On a quarterly basis, Non-Current Deferred Tax Liability fell 37.78% year-over-year to $15.0 million in Q1 2026; TTM through Mar 2026 was $15.0 million, a 37.78% decrease from a year earlier, with the FY2025 full-year figure at $22.5 million, down 1.23% from the prior year.
- Non-Current Deferred Tax Liability for Q1 2026 stood at $15.0 million, down from $22.5 million in the prior quarter.
- Over the last five years, Non-Current Deferred Tax Liability for RGEN reached as high as $39.3 million in Q4 2023 and fell as low as $14.5 million in Q3 2023.
- Historically, Non-Current Deferred Tax Liability has averaged $25.1 million across 5 years, with a median of $23.3 million in 2025.
- On a YoY basis, Non-Current Deferred Tax Liability climbed as much as 131.93% in 2024 and fell as far as 42.08% in 2024.
- Year by year, Non-Current Deferred Tax Liability stood at $23.0 million in 2022, then soared by 70.97% to $39.3 million in 2023, then plunged by 42.08% to $22.8 million in 2024, then declined by 1.23% to $22.5 million in 2025, then sank by 33.24% to $15.0 million in 2026.
- Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $15.0 million in Q1 2026, $22.5 million in Q4 2025, and $20.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Repligen | 7.75 Bn | 6.77 Bn | 108.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.02 Mn |
| Mar 31, 2026 | 15.02 Mn |
| Dec 31, 2025 | 22.50 Mn |
| Dec 31, 2025 | 22.50 Mn |
| Sep 30, 2025 | 20.14 Mn |
| Sep 30, 2025 | 20.14 Mn |
| Jun 30, 2025 | 23.33 Mn |
| Jun 30, 2025 | 23.33 Mn |
| Mar 31, 2025 | 24.14 Mn |
| Mar 31, 2025 | 24.14 Mn |
| Dec 31, 2024 | 22.78 Mn |
| Dec 31, 2024 | 22.78 Mn |
| Sep 30, 2024 | 33.69 Mn |
| Sep 30, 2024 | 33.69 Mn |
| Jun 30, 2024 | 34.04 Mn |
| Jun 30, 2024 | 34.04 Mn |
| Mar 31, 2024 | 36.81 Mn |
| Mar 31, 2024 | 36.81 Mn |
| Dec 31, 2023 | 39.32 Mn |
| Dec 31, 2023 | 39.32 Mn |